In particular, XIST could inhibit HCC cell proliferation and metastasis by sponging miR-92b, whose oncogenic role was demonstrated in vitro and in vivo and is at least partly due to the regulation of its target Smad7 [87]. The gene discussed is XIST; the disease is hepatocellular carcinoma.